Post by PPD

Precision neuroscience requires more than precision science. As biomarker-driven central nervous system (CNS) trials become more common, sponsors face growing operational complexity, from patient identification and diagnostics to data integration and decentralized trial delivery. Our latest blog explores the evolving landscape of biomarker-driven CNS research.